Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summary

Eugenio De Corso, Hannah Jaffee, Xander Bertels, Victor Gascon Moreno, Mitchell Silva

Open source

DOI: 10.1080/14712598.2026.2719891
Published: 2026-08-26
Container: Expert Opinion on Biological Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14712598.2026.2719891,
  title = {Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summary},
  author = {Eugenio De Corso and Hannah Jaffee and Xander Bertels and Victor Gascon Moreno and Mitchell Silva},
  year = {2026},
  journal = {Expert Opinion on Biological Therapy},
  doi = {10.1080/14712598.2026.2719891},
  url = {https://doi.org/10.1080/14712598.2026.2719891}
}

RIS

TY  - JOUR
TI  - Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summary
AU  - Eugenio De Corso
AU  - Hannah Jaffee
AU  - Xander Bertels
AU  - Victor Gascon Moreno
AU  - Mitchell Silva
PY  - 2026
JO  - Expert Opinion on Biological Therapy
DO  - 10.1080/14712598.2026.2719891
UR  - https://doi.org/10.1080/14712598.2026.2719891
ER  -

APA

Corso, E. D., Jaffee, H., Bertels, X., Moreno, V. G., & Silva, M. (2026). Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summary. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2026.2719891

Source records

crossref · retrieved 2026-09-27T00:46:47.751Z